New Diagnostic Modalities in Refining Diagnoses in Haematological Malignancies
In 2008 the WHO Classifications for haematological malignancies were re-classified. Since 2008, there has been new evolving technologies and subtypes. The presentation will review the 2008 WHO Classifications and the technology that was used for these classifications. Then the presentation will focus on the discussion of today’s new technologies and how new subtypes have emerge in the laboratories. Genetic technology is explored as the diagnostic tool of these subtypes and how this technology has improved diagnosis and possible patient treatments.
- Review of the WHO Classifications and the technology of 2008 will be discussed.
- A review of the changing technology for these malignancies will be explored.
- A discussion of how genetic technology has improved subclasses and possible diagnosis of the malignancies.
- Review of the current status of genetic testing and technology for heamatological malignancies subclasses.
If you have viewed this educational webinar, training or tutorial on Knowledge Pathway and would like to apply for continuing education credits with your certifying organization, please download the form to assist you in adding self-reported educational credits to your transcript.Apply for self-reported educational credits
For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted. Leica Biosystems and the editors hereby disclaim any liability arising directly or indirectly from the use of the content, including from any drugs, devices, techniques or procedures described in the content.
Copyright © 2021 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.